NCT06989437 - A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue | Biotech Hunter

Enrollment

982

Participants

Timeline

Start Date

October 3, 2025

Primary Completion Date

January 30, 2028

Study Completion Date

December 23, 2029

Conditions

CachexiaMetastatic Pancreatic Ductal Adenocarcinoma

Interventions

DRUG

ponsegromab

Double-Blind ponsegromab Treatment

DRUG

placebo

Double-Blind placebo Treatment

Trial Locations (12)

5037

NOT_YET_RECRUITING

ICON Cancer Centre - Kurralta Park, Kurralta Park

60451

NOT_YET_RECRUITING

Hope and Healing Cancer Services New Lenox, New Lenox

60521

NOT_YET_RECRUITING

Hope and Healing Cancer Services, Hinsdale

89502

RECRUITING

Renown Health Medical Oncology, Reno

RECRUITING

Renown Office of Clinical Research, Reno

RECRUITING

Renown Regional Medical Center, Reno

4941492

NOT_YET_RECRUITING

Rabin Medical Center, Petah Tikva

565-0871

NOT_YET_RECRUITING

The University of Osaka Hospital, Suita

755-8505

NOT_YET_RECRUITING

Yamaguchi University Hospital, Ube

811-1395

NOT_YET_RECRUITING

National Hospital Organization Kyushu Cancer Center, Fukuoka

641-8510

NOT_YET_RECRUITING

Wakayama Medical University Hospital, Wakayama

00935

RECRUITING

Pan American Center for Oncology Trials, LLC, Rio Piedras